S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
BREAKING: Tiny biotech successfully treats blindness (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
BREAKING: Tiny biotech successfully treats blindness (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
BREAKING: Tiny biotech successfully treats blindness (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
Options Trading Plan–Perfect For Beginners (Ad)
Stock market today: Wall Street higher, but likely not enough to this turn losing week into a winner
Analysts Recommend These Mining Stocks Before Metal Prices Rally
Options Trading Plan–Perfect For Beginners (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Challenges Hit Broadcom Stock, But Analysts See EPS Growth
BREAKING: Tiny biotech successfully treats blindness (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
NASDAQ:GEHC

GE HealthCare Technologies (GEHC) Stock Forecast, Price & News

$63.89
-1.12 (-1.72%)
(As of 09/21/2023 ET)
Compare
Today's Range
$63.79
$64.89
50-Day Range
$63.89
$82.63
52-Week Range
$53.00
$87.83
Volume
2.17 million shs
Average Volume
2.95 million shs
Market Capitalization
$29.06 billion
P/E Ratio
N/A
Dividend Yield
0.19%
Price Target
$88.44

GE HealthCare Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.62 Rating Score
Upside/​Downside
38.4% Upside
$88.44 Price Target
Short Interest
Healthy
2.89% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.88mentions of GE HealthCare Technologies in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$1.21 M Sold Last Quarter
Proj. Earnings Growth
13.42%
From $3.80 to $4.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.78 out of 5 stars

Medical Sector

73rd out of 965 stocks

X-Ray Apparatus & Tubes Industry

2nd out of 5 stocks


GEHC stock logo

About GE HealthCare Technologies (NASDAQ:GEHC) Stock

GE HealthCare Technologies Inc. is a leading player in the medical industry, specializing in developing and manufacturing advanced healthcare technologies. With a strong commitment to improving patient outcomes and advancing medical science, the company has established itself as a trusted provider of innovative solutions for healthcare professionals worldwide.

The mission of GE HealthCare Technologies Inc. is to revolutionize healthcare through cutting-edge technology and collaboration. By leveraging its expertise in medical imaging, diagnostics, and biopharmaceutical manufacturing, the company aims to enable healthcare providers to deliver more precise diagnoses, personalized treatment options, and better patient care.

Headquartered in Chicago, Illinois, GE HealthCare Technologies Inc. has a global presence, with operations spanning multiple countries. Its products and services cater to various medical specialties, including radiology, cardiology, oncology, neurology, and more. The company's comprehensive portfolio encompasses medical imaging systems, diagnostic tools, pharmaceutical manufacturing equipment, and digital health solutions.

GE HealthCare Technologies Inc. serves a diverse customer base, including hospitals, clinics, research institutions, and pharmaceutical companies. The company has established strategic partnerships with leading healthcare providers and organizations to drive collaborative innovation and address pressing healthcare challenges.

GE HealthCare Technologies Inc. is led by a dynamic management team with extensive experience in the healthcare industry. The company's Chief Executive Officer (CEO) is Peter Arduini, a seasoned executive known for his strategic vision and operational expertise. Under his leadership, GE HealthCare Technologies Inc. has consistently pursued innovation and growth opportunities.

Jan Makela serves as the CEO of Imaging, overseeing the company's imaging solutions portfolio. With a strong background in medical technology and a focus on customer-centric innovation, Makela has played a crucial role in developing cutting-edge imaging technologies.

GE HealthCare Technologies Inc. has demonstrated strong financial performance in recent years, with consistent revenue growth and solid profit margins. The company's annual sales reached an impressive $18.34 billion in 2022, reflecting its position as a key player in the medical technology industry.

GE HealthCare Technologies Inc. has maintained a healthy financial position, with a favorable price-to-earnings ratio, indicating investor confidence in the company's future earnings potential. The forward-looking price-to-earnings-growth ratio of 3 suggests that the company is well-positioned for sustainable long-term growth.

The company's profitability is further highlighted by its impressive price-to-sales ratio, which indicates that investors are willing to pay a premium for GE HealthCare Technologies Inc.'s products and services. The company's strong cash flow position demonstrates the company's ability to generate substantial cash and reinvest in research and development initiatives.

GE HealthCare Technologies Inc. operates within the broader medical technology industry, encompassing various sub-sectors such as medical imaging, diagnostics, and biopharmaceutical manufacturing. This industry is characterized by rapid technological advancements, increasing demand for innovative solutions, and a growing emphasis on personalized patient care.

Competitors in the medical technology sector include established companies such as Siemens Healthineers, Philips Healthcare, Medtronic, and smaller niche players. GE Healthcare Technologies Inc. distinguishes itself through its diverse product portfolio, global presence, and commitment to continuous innovation.

The company's competitive advantage lies in its strong research and development capabilities, technological expertise, and strategic partnerships. These factors enable GE HealthCare Technologies Inc. to introduce cutting-edge solutions, improve patient outcomes and maintain a strong market position.

GE HealthCare Technologies Inc. is well-positioned to seize growth opportunities in the medical technology industry. The company can capitalize on several factors, including advancements in artificial intelligence and machine learning, increased demand for digital health solutions, and the rising prevalence of chronic diseases.

By leveraging its technological expertise, GE HealthCare can continue to develop innovative products and services that address these industry trends. Additionally, expanding into emerging markets, forging strategic partnerships, and pursuing acquisitions can provide avenues for further growth and market expansion.

While GE HealthCare Technologies Inc. has demonstrated resilience and growth potential, it faces risks and challenges inherent to the medical technology industry. Regulatory changes, evolving reimbursement models, and intense competition can impact the company's operations and profitability.

To mitigate these risks, GE HealthCare Technologies Inc. employs robust risk management strategies, including continuous monitoring of regulatory developments, diversification of product offerings, and proactive engagement with healthcare stakeholders. The company's strong research and development capabilities and focus on innovation allow it to adapt to evolving market dynamics and stay ahead of the competition.

GEHC Price History

GEHC Stock News Headlines

Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to.
Disney's Big Breakup? Wall Street, Iger Ponder A Magical Split (GEHC)
Disney is facing decisions about a potential split, with a focus on core businesses like streaming, parks, and film studios. CEO Bob Iger remains noncommittal.
Reverse ‘money machines’ popping up across America
If you’ve been to a concert venue, stadium, or airport, you’ve almost certainly walked by one without knowing. The experts are calling it a 'Reverse ATM' Why are these machines suddenly appearing out of nowhere? And what does it mean for your money?
Citi Is Bullish On 125-Year-Old GE HealthCare Stock
The Real Reason They Murdered JFK?
Some people believe JFK was murdered because of his executive order 11110 that would have reduced the power of the Federal Reserve. Regardless if that’s true or not… The Fed is now involved in a new controversy that could have drastic consequences for the US dollar.
GE Healthcare Technologies Inc (GEHC) Gets a Buy from Citi
IQ-AI Shares Rise After GE HealthCare Agreement
GE Brings Good Things (Its Shares) Back to Life
See More Headlines
Receive GEHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GE HealthCare Technologies and its competitors with MarketBeat's FREE daily newsletter.

GEHC Company Calendar

Ex-Dividend for 8/15 Dividend
7/20/2023
Last Earnings
7/25/2023
Dividend Payable
8/15/2023
Today
9/22/2023
Next Earnings (Estimated)
10/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GEHC
Fax
N/A
Employees
50,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$88.44
High Stock Price Forecast
$97.00
Low Stock Price Forecast
$80.00
Forecasted Upside/Downside
+38.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.62
Research Coverage
13 Analysts

Profitability

Net Income
$1.92 billion
Pretax Margin
16.98%

Debt

Sales & Book Value

Annual Sales
$19.04 billion
Cash Flow
$5.81 per share
Book Value
$20.59 per share

Miscellaneous

Free Float
453,883,000
Market Cap
$29.06 billion
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Peter J. Arduini (Age 58)
    Pres, CEO & Director
    Comp: $2.26M
  • Mr. Frank R. Jimenez Esq. (Age 58)
    Gen. Counsel & Corp. Sec.
    Comp: $1.85M
  • Ms. Betty D. Larson (Age 47)
    Chief People Officer
    Comp: $1.78M
  • Mr. Jan Makela (Age 54)
    Pres & CEO of Imaging
    Comp: $955.06k
  • Mr. James K. Saccaro (Age 50)
    VP & CFO
  • Mr. George Andrew Newcomb (Age 56)
    Controller & Chief Accounting Officer
  • Dr. Taha Kass-Hout M.D. (Age 51)
    M.S., Chief Technology Officer
  • Mr. Thomas J. Westrick (Age 54)
    Chief Exec. Officer of Patient Care Solutions
  • Mr. Kenneth R. Stacherski (Age 51)
    Chief Global Supply Chain & Service Officer
  • Mr. Robert M. Giglietti
    VP, Treasurer & Mang.













GEHC Stock - Frequently Asked Questions

Should I buy or sell GE HealthCare Technologies stock right now?

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There are currently 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GEHC shares.
View GEHC analyst ratings
or view top-rated stocks.

What is GE HealthCare Technologies' stock price forecast for 2023?

13 Wall Street research analysts have issued 1-year price objectives for GE HealthCare Technologies' stock. Their GEHC share price forecasts range from $80.00 to $97.00. On average, they anticipate the company's stock price to reach $88.44 in the next year. This suggests a possible upside of 38.4% from the stock's current price.
View analysts price targets for GEHC
or view top-rated stocks among Wall Street analysts.

How have GEHC shares performed in 2023?

GE HealthCare Technologies' stock was trading at $59.00 at the beginning of the year. Since then, GEHC shares have increased by 8.3% and is now trading at $63.89.
View the best growth stocks for 2023 here
.

Are investors shorting GE HealthCare Technologies?

GE HealthCare Technologies saw a increase in short interest in August. As of August 31st, there was short interest totaling 11,320,000 shares, an increase of 37.9% from the August 15th total of 8,210,000 shares. Based on an average daily trading volume, of 3,260,000 shares, the days-to-cover ratio is presently 3.5 days. Currently, 2.9% of the company's stock are sold short.
View GE HealthCare Technologies' Short Interest
.

When is GE HealthCare Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, October 24th 2023.
View our GEHC earnings forecast
.

How were GE HealthCare Technologies' earnings last quarter?

GE HealthCare Technologies Inc. (NASDAQ:GEHC) issued its quarterly earnings data on Tuesday, July, 25th. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.05. The company earned $4.82 billion during the quarter, compared to analyst estimates of $4.79 billion. GE HealthCare Technologies's revenue for the quarter was up 7.4% compared to the same quarter last year.

How often does GE HealthCare Technologies pay dividends? What is the dividend yield for GE HealthCare Technologies?

GE HealthCare Technologies announced a quarterly dividend on Friday, June 23rd. Stockholders of record on Friday, July 21st will be paid a dividend of $0.03 per share on Tuesday, August 15th. This represents a $0.12 annualized dividend and a yield of 0.19%. The ex-dividend date is Thursday, July 20th.
Read our dividend analysis for GEHC
.

Is GE HealthCare Technologies a good dividend stock?

GE HealthCare Technologies (NASDAQ:GEHC) pays an annual dividend of $0.12 per share and currently has a dividend yield of 0.18%.
Read our dividend analysis for GEHC.

What guidance has GE HealthCare Technologies issued on next quarter's earnings?

GE HealthCare Technologies updated its FY 2023 earnings guidance on Tuesday, July, 25th. The company provided earnings per share guidance of $3.70-$3.85 for the period, compared to the consensus estimate of $3.74. The company issued revenue guidance of -.

What is GE HealthCare Technologies' stock symbol?

GE HealthCare Technologies trades on the NASDAQ under the ticker symbol "GEHC."

Who are GE HealthCare Technologies' major shareholders?

GE HealthCare Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include General Electric Co. (13.54%), Capital Research Global Investors (10.90%), BlackRock Inc. (6.32%), State Street Corp (4.15%), Geode Capital Management LLC (1.63%) and Bank of New York Mellon Corp (0.89%). Insiders that own company stock include H Lawrence Culp Jr, Jan Makela, Kevin Michael O'neill and Roland Rott.
View institutional ownership trends
.

How do I buy shares of GE HealthCare Technologies?

Shares of GEHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is GE HealthCare Technologies' stock price today?

One share of GEHC stock can currently be purchased for approximately $63.89.

How much money does GE HealthCare Technologies make?

GE HealthCare Technologies (NASDAQ:GEHC) has a market capitalization of $29.06 billion and generates $19.04 billion in revenue each year.

How many employees does GE HealthCare Technologies have?

The company employs 50,000 workers across the globe.

How can I contact GE HealthCare Technologies?

The official website for the company is www.gehealthcare.com. The company can be reached via phone at 617-443-3400 or via email at investor@gehealthcare.com.

This page (NASDAQ:GEHC) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -